• Thumbnail for COVID-19 drug development
    COVID-19 drug development is the research process to develop preventative therapeutic prescription drugs that would alleviate the severity of coronavirus...
    90 KB (13,124 words) - 04:28, 26 July 2024
  • Thumbnail for COVID-19 drug repurposing research
    safe drugs with repurposing potential against COVID-19. Drug repurposing usually requires three steps before taking the drug across the development pipeline:...
    128 KB (14,816 words) - 01:34, 9 September 2024
  • Thumbnail for Nirmatrelvir/ritonavir
    United States Food and Drug Administration (FDA) granted nirmatrelvir/ritonavir emergency use authorization (EUA) to treat COVID19. It was approved in the...
    67 KB (6,032 words) - 10:06, 8 September 2024
  • therefore was haram or forbidden for purposes of Islamic law. COVID19 drug development COVID19 drug repurposing research "(OWID) vaccination maps". Our World...
    200 KB (22,796 words) - 05:34, 12 September 2024
  • Thumbnail for Lianhua Qingwen
    Lianhua Qingwen (category COVID-19 drug development)
    ingredient used to make the drug methamphetamine. Despite the ban, Lianhua Qingwen has been sold illegally in Australia as a COVID-19 treatment. Liang, Xinlu...
    16 KB (1,667 words) - 09:45, 15 August 2024
  • Thumbnail for Pfizer–BioNTech COVID-19 vaccine
    The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company...
    260 KB (22,082 words) - 05:55, 13 September 2024
  • Thumbnail for Nirmatrelvir
    Nirmatrelvir (category COVID-19 drug development)
    could be replaced by a rigid pyrrolidone. These drugs had been further developed prior to the COVID-19 pandemic for other diseases including SARS. The...
    25 KB (2,010 words) - 16:27, 30 August 2024
  • Pemivibart (category COVID-19 drug development)
    authorized for the pre-exposure prophylaxis (prevention) of COVID19. The US Food and Drug Administration (FDA) issued an emergency use authorization for...
    7 KB (399 words) - 02:33, 16 September 2024
  • Thumbnail for Chloroquine and hydroxychloroquine during the COVID-19 pandemic
    for COVID-19. Neither drug has been useful to prevent or treat SARS-CoV-2 infection. Administration of chloroquine or hydroxychloroquine to COVID-19 patients...
    59 KB (5,538 words) - 20:50, 13 September 2024
  • Thumbnail for Molnupiravir
    Molnupiravir (category COVID-19 drug development)
    potential COVID-19 drug". Science. doi:10.1126/science.abc7055. Cully M (January 2022). "A tale of two antiviral targets - and the COVID-19 drugs that bind...
    54 KB (4,223 words) - 21:58, 7 September 2024
  • Thumbnail for Drug development
    Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug...
    26 KB (2,861 words) - 11:27, 24 July 2024
  • Thumbnail for History of COVID-19 vaccine development
    prepare for an outbreak and hasten the development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented...
    122 KB (11,033 words) - 22:07, 17 July 2024
  • Thumbnail for Development of COVID-19 tests
    developing a therapy against COVID-19 was progressing at a pandemic speed, yet there is no effective therapy approved by food and drug administration (FDA)....
    55 KB (5,313 words) - 19:42, 12 September 2024
  • Thumbnail for Baricitinib
    Baricitinib (category COVID-19 drug development)
    treating people with COVID-19. The drug's anti-inflammatory activity was expected to act on the inflammatory cascade associated with COVID-19. In April and June...
    43 KB (3,613 words) - 02:13, 16 July 2024
  • Thumbnail for Remdesivir
    Remdesivir (category COVID-19 drug development)
    Technology to Enable the Formulation of Remdesivir in Treating COVID-19". Drug Development & Delivery. Archived from the original on 20 July 2020. Retrieved...
    113 KB (9,807 words) - 01:49, 16 July 2024
  • Thumbnail for Deuremidevir
    Deuremidevir (category COVID-19 drug development)
    duration of COVID-19 symptoms in non-hospitalized adults with mild-to-moderate disease compared to placebo. Junshi, which markets the drug, received conditional...
    5 KB (481 words) - 07:29, 14 August 2024
  • Thumbnail for Simnotrelvir/ritonavir
    Simnotrelvir/ritonavir (category COVID-19 drug development)
    Xiannuoxin) is a pharmaceutical drug used for the treatment of COVID-19. Simnotrelvir/ritonavir is a combination drug of simnotrelvir, an inhibitor of...
    8 KB (334 words) - 16:03, 9 August 2024
  • Thumbnail for Dexamethasone
    Dexamethasone (category COVID-19 drug development)
    acknowledged. "EMA to review results from study testing common steroid drug against COVID-19". Reuters. 24 July 2020. Archived from the original on 27 July 2020...
    68 KB (5,999 words) - 20:41, 31 August 2024
  • Thumbnail for Ensitrelvir
    Ensitrelvir (category COVID-19 drug development)
    Japan to accelerate the progression to market of other antiviral drugs targeting COVID-19, including remdesivir and molnupiravir. In a study of 428 patients...
    17 KB (1,228 words) - 07:01, 9 September 2024
  • Thumbnail for Favipiravir
    Favipiravir (category COVID-19 drug development)
    of mild to moderate COVID-19 in Egypt, Hungary and Serbia. Patients are required to sign a consent form before obtaining the drug.[citation needed] Favipiravir...
    35 KB (3,139 words) - 21:09, 12 August 2024
  • Levilimab (category COVID-19 drug development)
    approved as a treatment for COVID-19 in Russia. Harrison, Charlotte (1 August 2020). "Focus shifts to antibody cocktails for COVID-19 cytokine storm". Nature...
    4 KB (234 words) - 17:45, 25 April 2024
  • Thumbnail for Covid-Organics
    president of Madagascar, claims can prevent and cure Coronavirus disease 2019 (COVID-19). The drink is produced from a species under the Artemisia genus from which...
    16 KB (1,462 words) - 08:15, 29 June 2024
  • Thumbnail for COVID-19 pandemic in the United States
    and Drug Administration (FDA). Retrieved December 1, 2020. "Coronavirus (COVID-19) Update: FDA Authorizes Drug Combination for Treatment of COVID-19". US...
    174 KB (19,757 words) - 01:07, 18 September 2024
  • Thumbnail for MK-7845
    MK-7845 (category COVID-19 drug development)
    experimental antiviral medication being studied as a potential treatment for COVID-19. It is believed to work by inhibiting SARS-CoV-2 main protease (3CLpro)...
    7 KB (581 words) - 12:55, 9 September 2024
  • Thumbnail for Casirivimab/imdevimab
    after testing positive for COVID19. In January 2021, the United States agreed to purchase 1.25 million doses of the drug for $2.625 billion, at $2,100...
    49 KB (3,403 words) - 03:31, 7 September 2024
  • Bamlanivimab/etesevimab (category COVID-19 drug development)
    2022. "FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19". U.S. Food and Drug Administration (FDA) (Press release). 10 February 2021. Retrieved...
    16 KB (1,301 words) - 07:13, 18 July 2024
  • Thumbnail for Janssen COVID-19 vaccine
    The Janssen COVID19 vaccine, sold under the brand name Jcovden, is a COVID19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands, and...
    141 KB (11,328 words) - 07:32, 10 August 2024
  • Thumbnail for Tipiracil
    Tipiracil (category COVID-19 drug development)
    Tipiracil is a drug used in the treatment of cancer. It is approved for use in form of the combination drug trifluridine/tipiracil for the treatment of...
    7 KB (567 words) - 07:53, 16 November 2023
  • Thumbnail for Novavax COVID-19 vaccine
    The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the...
    73 KB (5,473 words) - 01:56, 17 September 2024
  • Vilobelimab (category COVID-19 drug development)
    inflammation and worsening of COVID-19. Vilobelimab was granted an emergency use authorization (EUA) by the US Food and Drug Administration (FDA) in April...
    8 KB (440 words) - 06:30, 28 December 2023